TRT News and Press, Trio-Tech International From 05/15/23

2023-05-15 11:56:20 ET Trio-Tech press release ( NYSE: TRT ): Q3 GAAP EPS of $0.00. Revenue of $9.8M (-12.0% Y/Y). For further details see: Trio-Tech GAAP EPS of $0.00, revenue of $9.8M

Trio-Tech International (NYSE MKT: TRT) today announced financial results for the third quarter and first nine months of fiscal 2023, and announced its initial contract for its Dynamic HTOL Electric Vehicle Power Module Test System Third Quarter Results Revenue for the third fiscal ...

Trio-Tech press release ( NYSE: TRT ): Q2 GAAP EPS of $0.12. Revenue of $12.39M (+13.5% Y/Y). For further details see: Trio-Tech GAAP EPS of $0.12, revenue of $12.39M

Trio-Tech International (NYSE MKT: TRT) today announced financial results for the second quarter and first six months of fiscal 2023. Fiscal 2023 Second Quarter Results For the three months ended December 31, 2022, revenue increased 13% to $12,390,000, compared to $10,922,000 for th...

Trio-Tech press release ( NYSE: TRT ): Q1 GAAP EPS of $0.21. Revenue of $11.94M (+17.4% Y/Y). For further details see: Trio-Tech GAAP EPS of $0.21, revenue of $11.94M

Trio-Tech press release ( NYSE: TRT ): Q4 GAAP EPS of $0.19. Revenue of $11.83M (+27.1% Y/Y). Shares +10% . For further details see: Trio-Tech GAAP EPS of $0.19, revenue of $11.83M

Fourth Quarter Net Income Increased to $0.19 Per Share Versus a Loss of $0.25 Per Share on 27% Revenue Gain Trio-Tech International (NYSE MKT: TRT) today announced financial results for the fourth quarter and fiscal year ended June 30, 2022. Fiscal 2022 Res...

Trio-Tech press release (NYSE:TRT): Q3 GAAP EPS of -$0.04. Revenue of $11.14M (+37.4% Y/Y). For further details see: Trio-Tech GAAP EPS of -$0.04, revenue of $11.14M

Trio-Tech International (NYSE MKT: TRT) today announced financial results for the third quarter and first nine months of fiscal 2022. Third Quarter Results Revenue for the third fiscal quarter increased 37% to $11,138,000 from $8,112,000 for the same quarter of fiscal 20...

We advised the subscribers to our research to buy TRT at $3 per share in July 2020. The stock has more than doubled since our buy recommendation and we have locked in our profits. However, TRT's fundamentals remain strong and outlook is positive. Therefore, the stock still has...